cladribine

Cladribine is used for as a first and second-line treatment for symptomatic hairy cell leukemia and for B-cell chronic lymphocytic leukemia and is administered by intravenous or subcutaneous infusion. It is sold under the brand name Leustatin and Mavenclad.. Reference standards of Cladribine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

No Data Found